Detalles de la búsqueda
1.
A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring EML4-ALK rearrangement.
Transl Lung Cancer Res;
13(5): 1150-1162, 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38854939
2.
Antibody-drug conjugate development: opening windows for EGFR-mutant EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancers?
Transl Lung Cancer Res;
13(4): 936-939, 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38736493
3.
PD-1-induced encephalopathy: a report of 2 cases on neurological toxicities with immune checkpoint inhibitors.
Transl Cancer Res;
13(2): 1196-1207, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38482411
4.
Downregulation of homeobox B8 in attenuating non-small cell lung cancer cell migration and invasion though the epithelial-mesenchymal transition pathway.
Transl Cancer Res;
13(1): 413-422, 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38410214
5.
Anaplastic lymphoma kinase inhibitor development: enhanced delivery to the central nervous system.
Transl Lung Cancer Res;
12(8): 1822-1825, 2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37691872
6.
First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trial.
Cancer Med;
12(16): 17061-17067, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37641544
7.
Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced EGFR+non-small-cell lung cancer.
Transl Lung Cancer Res;
12(6): 1167-1184, 2023 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37425411
8.
Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors.
Target Oncol;
17(5): 597-604, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36087188
9.
Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer: Results of a phase 2, single-arm, open-label study.
Eur J Cancer;
172: 276-286, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35810553
10.
A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer.
Transl Lung Cancer Res;
11(4): 607-616, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35529793
11.
Sensitivity to dabrafenib and trametinib treatments in patients with non-small-cell cancer harboring BRAF compound mutations: A pooled analysis of BRAF p.V600E-positive advanced non-small-cell lung cancer.
Cancer Genet;
266-267: 1-6, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35598548
12.
Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma.
Front Oncol;
12: 966527, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36698400
13.
Smoking signature is superior to programmed death-ligand 1 expression in predicting pathological response to neoadjuvant immunotherapy in lung cancer patients.
Transl Lung Cancer Res;
10(9): 3807-3822, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34733630
14.
Japanese Lung Cancer Society Guidelines for Stage IV NSCLC With EGFR Mutations.
JTO Clin Res Rep;
2(1): 100107, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34589972
15.
Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study.
JTO Clin Res Rep;
2(3): 100135, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34589998
16.
Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma.
JTO Clin Res Rep;
2(6): 100178, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34590026
17.
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Cancer Sci;
112(12): 5000-5010, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543477
18.
Asthma caused by durvalumab after chemoradiotherapy in two patients with non-small cell lung cancer.
Respirol Case Rep;
9(9): e0835, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34457312
19.
A narrative review of primary research endpoints of neoadjuvant therapy for lung cancer: past, present and future.
Transl Lung Cancer Res;
10(7): 3264-3275, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34430363
20.
Pre-existing interstitial lung disease is associated with onset of nivolumab-induced pneumonitis in patients with solid tumors: a retrospective analysis.
BMC Cancer;
21(1): 924, 2021 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34399710